Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting

Bioconjugate Chemistry

Volumn 22, Issue 3, 2011, Pages 413-421

  Hoppmann, Susan ^a   Miao, Zheng ^a   Liu, Shuanglong ^a   Liu, Hongguang ^a   Ren, Gang ^a   Bao, Ande ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE TETRAACETIC ACIDMONO N HYDROXYSUCCINIMIDE ESTER IN 111; COPPER 64; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INDIUM 111; LUTETIUM 177; RADIOPHARMACEUTICAL AGENT; SERUM ALBUMIN; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL TRANSPORT; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DRUG DISTRIBUTION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; MOLECULE; MOUSE; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

MUS MUSCULUS;

EID: 79952809888     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100432h     Document Type: Article

References (38)

1. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. 1989, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244, 707-12 (Pubitemid 19147683)
2. Schneider, P. M., Hung, M. C., Chiocca, S. M., Manning, J., Zhao, X. Y., Fang, K., and Roth, J. A. (1989) Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer Cancer Res. 49, 4968-71 (Pubitemid 19239327)
3. Yokota, J., Yamamoto, T., Miyajima, N., Toyoshima, K., Nomura, N., Sakamoto, H., Yoshida, T., Terada, M., and Sugimura, T. (1988) Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue Oncogene 2, 283-7 (Pubitemid 18085309)
4. Nilsson, F. Y. and Tolmachev, V. (2007) Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy Curr. Opin. Drug Discovery Dev. 10, 167-75 (Pubitemid 46438646)
5. Nord, K., Gunneriusson, E., Ringdahl, J., Stahl, S., Uhlen, M., and Nygren, P. A. (1997) Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain Nat. Biotechnol. 15, 772-7 (Pubitemid 27329481)
6. Orlova, A., Magnusson, M., Eriksson, T. L., Nilsson, M., Larsson, B., Hoiden-Guthenberg, I., Widstrom, C., Carlsson, J., Tolmachev, V., Stahl, S., and Nilsson, F. Y. (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule Cancer Res. 66, 4339-48
7. Wikman, M., Steffen, A. C., Gunneriusson, E., Tolmachev, V., Adams, G. P., Carlsson, J., and Stahl, S. (2004) Selection and characterization of HER2/neu-binding affibody ligands Protein Eng. Des. Sel. 17, 455-62 (Pubitemid 39294720)
8. Tolmachev, V., Nilsson, F. Y., Widstrom, C., Andersson, K., Rosik, D., Gedda, L., Wennborg, A., and Orlova, A. (2006) 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors J. Nucl. Med. 47, 846-53 (Pubitemid 46772889)
9. Kramer-Marek, G., Kiesewetter, D. O., Martiniova, L., Jagoda, E., Lee, S. B., and Capala, J. (2008) [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 35, 1008-18
10. Tran, T., Engfeldt, T., Orlova, A., Sandstrom, M., Feldwisch, J., Abrahmsen, L., Wennborg, A., Tolmachev, V., and Karlstrom, A. E. (2007) 99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors Bioconjugate Chem. 18, 1956-64 (Pubitemid 350219996)
11. Steffen, A. C., Almqvist, Y., Chyan, M. K., Lundqvist, H., Tolmachev, V., Wilbur, D. S., and Carlsson, J. (2007) Biodistribution of 211At labeled HER-2 binding affibody molecules in mice Oncol. Rep. 17, 1141-7
12. Fortin, M. A., Orlova, A., Malmstrom, P. U., and Tolmachev, V. (2007) Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma Int. J. Mol. Med. 19, 285-91
13. Cheng, Z., De Jesus, O. P., Namavari, M., De, A., Levi, J., Webster, J. M., Zhang, R., Lee, B., Syud, F. A., and Gambhir, S. S. (2008) Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules J. Nucl. Med. 49, 804-13 (Pubitemid 351717547)
14. Lee, S. B., Hassan, M., Fisher, R., Chertov, O., Chernomordik, V., Kramer-Marek, G., Gandjbakhche, A., and Capala, J. (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging Clin. Cancer Res. 14, 3840-9
15. Ren, G., Zhang, R., Liu, Z., Webster, J. M., Miao, Z., Gambhir, S. S., Syud, F. A., and Cheng, Z. (2009) A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression J. Nucl. Med. 50, 1492-9
16. Cheng, Z., De Jesus, O. P., Kramer, D. J., De, A., Webster, J. M., Gheysens, O., Levi, J., Namavari, M., Wang, S., Park, J. M., Zhang, R., Liu, H., Lee, B., Syud, F. A., and Gambhir, S. S. (2010) 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors Mol. Imaging Biol. 12, 316-24
17. Engfeldt, T., Orlova, A., Tran, T., Bruskin, A., Widstrom, C., Karlstrom, A. E., and Tolmachev, V. (2007) Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl- glycyl-glycyl-glycyl (MAG3) sequence Eur. J. Nucl. Med. Mol. Imaging 34, 722-33 (Pubitemid 46669355)
18. Engfeldt, T., Tran, T., Orlova, A., Widstrom, C., Feldwisch, J., Abrahmsen, L., Wennborg, A., Karlstrom, A. E., and Tolmachev, V. (2007) 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule Eur. J. Nucl. Med. Mol. Imaging 34, 1843-53 (Pubitemid 47599054)
19. Orlova, A., Rosik, D., Sandstrom, M., Lundqvist, H., Einarsson, L., and Tolmachev, V. (2007) Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors Q. J. Nucl. Med. Mol. Imaging 51, 314-23 (Pubitemid 350267702)
20. Orlova, A., Tolmachev, V., Pehrson, R., Lindborg, M., Tran, T., Sandstrom, M., Nilsson, F. Y., Wennborg, A., Abrahmsen, L., and Feldwisch, J. (2007) Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors Cancer Res. 67, 2178-86 (Pubitemid 46424237)
21. Orlova, A., Tran, T., Widstrom, C., Engfeldt, T., Eriksson Karlstrom, A., and Tolmachev, V. (2007) Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2: 342), a potential agent for imaging of HER2 expression in malignant tumors Int. J. Mol. Med. 20, 397-404
22. Tolmachev, V., Velikyan, I., Sandstrom, M., and Orlova, A. (2010) A HER2-binding Affibody molecule labelled with (68)Ga for PET imaging: direct in vivo comparison with the (111)In-labelled analogue. Eur. J. Nucl. Med. Mol. Imaging.
23. Tran, T., Orlova, A., Sivaev, I., Sandstrom, M., and Tolmachev, V. (2007) Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand Int. J. Mol. Med. 19, 485-93
24. Tran, T. A., Ekblad, T., Orlova, A., Sandstrom, M., Feldwisch, J., Wennborg, A., Abrahmsen, L., Tolmachev, V., and Eriksson Karlstrom, A. (2008) Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules Bioconjugate Chem. 19, 2568-76
25. Gradishar, W. J. (2006) Albumin-bound paclitaxel: a next-generation taxane Expert Opin. Pharmacother. 7, 1041-53 (Pubitemid 43949942)
26. Chen, K., Xie, J., and Chen, X. (2009) RGD-human serum albumin conjugates as efficient tumor targeting probes Mol. Imaging 8, 65-73
27. Miao, Z., Ren, G., Liu, H., Jiang, L., and Cheng, Z. (2010) Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein Bioconjugate Chem. 21, 947-54
28. Stabin, M. G., Sparks, R. B., and Crowe, E. (2005) OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J. Nucl. Med. 46, 1023-7 (Pubitemid 43733519)
29. Eckerman, K. F. and Endo, A. (2008) MIRD: Radionuclide Data and Decay Schemes, Society of Nuclear Medicine, Reston.
30. Baum, R. P., Prasad, V., Muller, D., Schuchardt, C., Orlova, A., Wennborg, A., Tolmachev, V., and Feldwisch, J. (2010) Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules J. Nucl. Med. 51, 892-7
31. Tolmachev, V., Orlova, A., Pehrson, R., Galli, J., Baastrup, B., Andersson, K., Sandstrom, M., Rosik, D., Carlsson, J., Lundqvist, H., Wennborg, A., and Nilsson, F. Y. (2007) Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule Cancer Res. 67, 2773-82 (Pubitemid 46548966)
32. Tolmachev, V., Wallberg, H., Andersson, K., Wennborg, A., Lundqvist, H., and Orlova, A. (2009) The influence of Bz-DOTA and CHX-A''-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for (114m)In-mediated targeting therapy Eur. J. Nucl. Med. Mol. Imaging 36, 1460-8
33. Liu, S. (2006) Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging Mol. Pharm. 3, 472-87 (Pubitemid 44639125)
34. Liu, S. (2009) Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency Bioconjugate Chem. 20, 2199-213
35. Tang, Y., Wang, J., Scollard, D. A., Mondal, H., Holloway, C., Kahn, H. J., and Reilly, R. M. (2005) Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments Nucl. Med. Biol. 32, 51-8 (Pubitemid 40187381)
36. Smith-Jones, P. M., Solit, D. B., Akhurst, T., Afroze, F., Rosen, N., and Larson, S. M. (2004) Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors Nat. Biotechnol. 22, 701-6 (Pubitemid 38702826)
37. Adams, G. P., Shaller, C. C., Dadachova, E., Simmons, H. H., Horak, E. M., Tesfaye, A., Klein-Szanto, A. J., Marks, J. D., Brechbiel, M. W., and Weiner, L. M. (2004) A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice Cancer Res. 64, 6200-6 (Pubitemid 39136232)
38. Olafsen, T., Tan, G. J., Cheung, C. W., Yazaki, P. J., Park, J. M., Shively, J. E., Williams, L. E., Raubitschek, A. A., Press, M. F., and Wu, A. M. (2004) Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting Protein Eng. Des. Sel. 17, 315-23 (Pubitemid 39093511)